 James Feinstein
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nervous System Diseases | 8 | 2024 | 251 | 3.500 |
Why?
| | Polypharmacy | 10 | 2023 | 84 | 3.060 |
Why?
| | Epidermolysis Bullosa | 8 | 2024 | 59 | 3.020 |
Why?
| | Medicaid | 11 | 2024 | 431 | 2.700 |
Why?
| | International Classification of Diseases | 6 | 2024 | 122 | 2.660 |
Why?
| | Chronic Disease | 12 | 2024 | 1720 | 2.640 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2024 | 253 | 2.080 |
Why?
| | Physician-Patient Relations | 6 | 2024 | 540 | 1.660 |
Why?
| | Medication Therapy Management | 3 | 2023 | 72 | 1.610 |
Why?
| | Child | 59 | 2025 | 20884 | 1.410 |
Why?
| | Outpatients | 3 | 2024 | 373 | 1.270 |
Why?
| | Delivery of Health Care | 3 | 2023 | 898 | 1.110 |
Why?
| | Child, Preschool | 34 | 2024 | 10490 | 1.110 |
Why?
| | Drug Interactions | 6 | 2024 | 395 | 1.090 |
Why?
| | Prescription Drugs | 3 | 2017 | 112 | 0.980 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 155 | 0.980 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2023 | 40 | 0.970 |
Why?
| | Infant | 28 | 2024 | 8995 | 0.910 |
Why?
| | Cross-Sectional Studies | 14 | 2024 | 5075 | 0.830 |
Why?
| | Patient Care | 1 | 2024 | 108 | 0.830 |
Why?
| | Oral Health | 1 | 2024 | 123 | 0.810 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 252 | 0.800 |
Why?
| | Adolescent | 34 | 2024 | 20412 | 0.790 |
Why?
| | Pediatrics | 6 | 2022 | 1056 | 0.790 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 29 | 0.790 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 53 | 0.770 |
Why?
| | Parents | 2 | 2020 | 1316 | 0.760 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 12 | 0.710 |
Why?
| | Retrospective Studies | 30 | 2024 | 14522 | 0.700 |
Why?
| | Drug Utilization | 2 | 2019 | 171 | 0.700 |
Why?
| | Humans | 74 | 2025 | 129626 | 0.690 |
Why?
| | Drug Prescriptions | 2 | 2020 | 248 | 0.690 |
Why?
| | Hospitalization | 6 | 2024 | 2057 | 0.660 |
Why?
| | Symptom Assessment | 1 | 2020 | 125 | 0.650 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 767 | 0.630 |
Why?
| | Ambulatory Care | 4 | 2023 | 506 | 0.630 |
Why?
| | Analgesics | 1 | 2020 | 191 | 0.620 |
Why?
| | Cohort Studies | 13 | 2024 | 5426 | 0.600 |
Why?
| | Pharmaceutical Preparations | 2 | 2023 | 171 | 0.590 |
Why?
| | United States | 22 | 2025 | 13871 | 0.590 |
Why?
| | Drug Costs | 1 | 2019 | 100 | 0.580 |
Why?
| | Critical Illness | 1 | 2024 | 758 | 0.580 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 627 | 0.550 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 263 | 0.550 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 374 | 0.540 |
Why?
| | Health Priorities | 1 | 2017 | 34 | 0.530 |
Why?
| | Medication Adherence | 1 | 2021 | 558 | 0.520 |
Why?
| | Self-Injurious Behavior | 3 | 2023 | 124 | 0.510 |
Why?
| | Attitude to Death | 4 | 2024 | 67 | 0.510 |
Why?
| | Home Care Services | 3 | 2025 | 225 | 0.500 |
Why?
| | Male | 39 | 2024 | 63670 | 0.490 |
Why?
| | Skin Neoplasms | 1 | 2022 | 829 | 0.470 |
Why?
| | Software | 1 | 2018 | 608 | 0.420 |
Why?
| | Female | 35 | 2024 | 68734 | 0.410 |
Why?
| | Databases, Factual | 7 | 2024 | 1269 | 0.390 |
Why?
| | Terminally Ill | 2 | 2010 | 36 | 0.390 |
Why?
| | Algorithms | 2 | 2022 | 1616 | 0.380 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2739 | 0.370 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 913 | 0.360 |
Why?
| | Caregivers | 5 | 2025 | 806 | 0.360 |
Why?
| | Biomedical Research | 1 | 2017 | 640 | 0.350 |
Why?
| | Hospitals, Pediatric | 7 | 2020 | 513 | 0.350 |
Why?
| | Health Services Research | 3 | 2025 | 391 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2274 | 0.340 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1914 | 0.330 |
Why?
| | Mortality | 2 | 2009 | 307 | 0.310 |
Why?
| | Professional-Family Relations | 2 | 2009 | 142 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1271 | 0.290 |
Why?
| | Terminal Care | 2 | 2011 | 215 | 0.290 |
Why?
| | Child Mortality | 1 | 2007 | 15 | 0.280 |
Why?
| | Autopsy | 1 | 2007 | 90 | 0.280 |
Why?
| | Patient Preference | 1 | 2010 | 184 | 0.280 |
Why?
| | Child Welfare | 1 | 2007 | 210 | 0.250 |
Why?
| | Cause of Death | 1 | 2007 | 395 | 0.250 |
Why?
| | Medical History Taking | 1 | 2005 | 118 | 0.240 |
Why?
| | Prevalence | 3 | 2024 | 2564 | 0.240 |
Why?
| | Risk Assessment | 5 | 2020 | 3262 | 0.230 |
Why?
| | Infant, Newborn | 9 | 2024 | 5756 | 0.230 |
Why?
| | Health Services Accessibility | 2 | 2025 | 903 | 0.230 |
Why?
| | House Calls | 1 | 2005 | 124 | 0.220 |
Why?
| | Education, Medical, Undergraduate | 1 | 2007 | 178 | 0.220 |
Why?
| | Ontario | 1 | 2024 | 90 | 0.220 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1098 | 0.220 |
Why?
| | Internship and Residency | 2 | 2011 | 1050 | 0.220 |
Why?
| | Pharmacogenomic Testing | 1 | 2024 | 61 | 0.210 |
Why?
| | Health Equity | 1 | 2025 | 87 | 0.210 |
Why?
| | Family | 1 | 2007 | 646 | 0.210 |
Why?
| | Patient Safety | 3 | 2023 | 287 | 0.210 |
Why?
| | Dental Caries | 1 | 2024 | 154 | 0.210 |
Why?
| | World Health Organization | 1 | 2023 | 110 | 0.200 |
Why?
| | Seizures | 1 | 2005 | 401 | 0.190 |
Why?
| | Mobile Applications | 1 | 2024 | 161 | 0.190 |
Why?
| | Logistic Models | 3 | 2024 | 1986 | 0.190 |
Why?
| | Patient Discharge | 3 | 2021 | 836 | 0.190 |
Why?
| | Anemia | 1 | 2023 | 161 | 0.180 |
Why?
| | Canada | 2 | 2020 | 350 | 0.180 |
Why?
| | Age Factors | 4 | 2021 | 3152 | 0.180 |
Why?
| | Child, Hospitalized | 1 | 2021 | 52 | 0.180 |
Why?
| | Physicians | 1 | 2009 | 866 | 0.180 |
Why?
| | Pseudomonas aeruginosa | 1 | 2023 | 348 | 0.170 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 42 | 0.170 |
Why?
| | Multimorbidity | 1 | 2021 | 46 | 0.170 |
Why?
| | Medication Errors | 2 | 2024 | 96 | 0.170 |
Why?
| | Bronchiolitis | 1 | 2021 | 90 | 0.160 |
Why?
| | Data Collection | 2 | 2020 | 650 | 0.160 |
Why?
| | Critical Care | 1 | 2024 | 551 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 578 | 0.150 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 69 | 0.150 |
Why?
| | Biopsy, Needle | 1 | 2019 | 188 | 0.150 |
Why?
| | Programming Languages | 1 | 2018 | 23 | 0.150 |
Why?
| | Dilatation | 1 | 2018 | 61 | 0.150 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 51 | 0.150 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 151 | 0.150 |
Why?
| | Colorado | 2 | 2020 | 4404 | 0.150 |
Why?
| | Adult | 9 | 2024 | 35599 | 0.150 |
Why?
| | Fluoroscopy | 1 | 2018 | 157 | 0.140 |
Why?
| | Age Distribution | 1 | 2019 | 373 | 0.140 |
Why?
| | North America | 1 | 2019 | 292 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2023 | 492 | 0.140 |
Why?
| | Sex Distribution | 1 | 2019 | 360 | 0.140 |
Why?
| | Vulnerable Populations | 1 | 2019 | 156 | 0.140 |
Why?
| | Palliative Care | 3 | 2011 | 702 | 0.140 |
Why?
| | Patient-Centered Care | 1 | 2023 | 508 | 0.140 |
Why?
| | Young Adult | 7 | 2020 | 12455 | 0.140 |
Why?
| | Case Management | 1 | 2017 | 63 | 0.140 |
Why?
| | Esophagoscopy | 1 | 2018 | 198 | 0.140 |
Why?
| | Fee-for-Service Plans | 1 | 2017 | 87 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2023 | 715 | 0.140 |
Why?
| | Child Health | 1 | 2019 | 147 | 0.130 |
Why?
| | Nursing Staff, Hospital | 2 | 2011 | 149 | 0.130 |
Why?
| | Child Health Services | 3 | 2022 | 184 | 0.130 |
Why?
| | Influenza, Human | 1 | 2023 | 601 | 0.130 |
Why?
| | Managed Care Programs | 1 | 2017 | 133 | 0.130 |
Why?
| | Esophagus | 2 | 2018 | 248 | 0.130 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 337 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 367 | 0.130 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 389 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1269 | 0.120 |
Why?
| | Drug Labeling | 1 | 2015 | 41 | 0.120 |
Why?
| | Drug Therapy, Combination | 2 | 2018 | 1042 | 0.120 |
Why?
| | Sex Factors | 2 | 2019 | 1970 | 0.120 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1705 | 0.120 |
Why?
| | Pneumonia | 1 | 2021 | 617 | 0.120 |
Why?
| | Telemedicine | 1 | 2023 | 792 | 0.120 |
Why?
| | Neoplasms | 1 | 2009 | 2455 | 0.120 |
Why?
| | Pain | 1 | 2020 | 787 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1685 | 0.110 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 388 | 0.110 |
Why?
| | Duodenum | 1 | 2014 | 76 | 0.110 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 22 | 0.110 |
Why?
| | Utilization Review | 1 | 2014 | 36 | 0.110 |
Why?
| | Stomach | 1 | 2014 | 109 | 0.110 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2016 | 203 | 0.110 |
Why?
| | Terminology as Topic | 1 | 2015 | 203 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 175 | 0.110 |
Why?
| | Patient Readmission | 2 | 2021 | 653 | 0.110 |
Why?
| | Biomedical Technology | 1 | 2014 | 42 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2014 | 125 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2014 | 305 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2005 | 2342 | 0.100 |
Why?
| | Patient Admission | 1 | 2014 | 183 | 0.100 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 219 | 0.100 |
Why?
| | Quality Improvement | 1 | 2020 | 1101 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4894 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2641 | 0.100 |
Why?
| | Risk Factors | 4 | 2021 | 9786 | 0.100 |
Why?
| | Mental Disorders | 1 | 2020 | 1034 | 0.100 |
Why?
| | Endoscopy, Digestive System | 1 | 2013 | 123 | 0.090 |
Why?
| | Comorbidity | 3 | 2023 | 1547 | 0.090 |
Why?
| | Quality of Life | 1 | 2023 | 2688 | 0.090 |
Why?
| | Organ Transplantation | 1 | 2014 | 228 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2627 | 0.090 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 198 | 0.090 |
Why?
| | Bereavement | 1 | 2011 | 48 | 0.090 |
Why?
| | Anecdotes as Topic | 1 | 2010 | 7 | 0.080 |
Why?
| | Drug Overdose | 1 | 2014 | 322 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 2882 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2007 | 1280 | 0.080 |
Why?
| | Pharmacoepidemiology | 2 | 2019 | 20 | 0.070 |
Why?
| | Domestic Violence | 1 | 2008 | 50 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 1947 | 0.070 |
Why?
| | Shellfish | 1 | 2005 | 6 | 0.060 |
Why?
| | Humanism | 1 | 2005 | 5 | 0.060 |
Why?
| | Interviews as Topic | 2 | 2025 | 704 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2010 | 617 | 0.060 |
Why?
| | Health Care Surveys | 2 | 2017 | 557 | 0.060 |
Why?
| | Anaphylaxis | 1 | 2005 | 98 | 0.060 |
Why?
| | Residence Characteristics | 1 | 2007 | 331 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 524 | 0.050 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 28 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2720 | 0.050 |
Why?
| | Food Hypersensitivity | 1 | 2005 | 176 | 0.050 |
Why?
| | Hospitals | 1 | 2007 | 637 | 0.050 |
Why?
| | Communication | 2 | 2023 | 838 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 375 | 0.050 |
Why?
| | Nursing Homes | 1 | 2023 | 157 | 0.040 |
Why?
| | Mupirocin | 1 | 2020 | 7 | 0.040 |
Why?
| | Iron | 1 | 2023 | 282 | 0.040 |
Why?
| | Prognosis | 1 | 2009 | 3774 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2023 | 353 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 618 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 246 | 0.040 |
Why?
| | Primary Health Care | 2 | 2022 | 1686 | 0.040 |
Why?
| | Pharmacovigilance | 1 | 2019 | 21 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1365 | 0.040 |
Why?
| | Clinical Competence | 1 | 2005 | 1017 | 0.040 |
Why?
| | Health Expenditures | 1 | 2020 | 180 | 0.040 |
Why?
| | Qualitative Research | 1 | 2025 | 1219 | 0.040 |
Why?
| | Adolescent Health Services | 1 | 2019 | 75 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2017 | 97 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 314 | 0.030 |
Why?
| | Mental Health Services | 1 | 2022 | 404 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 653 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 516 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 434 | 0.030 |
Why?
| | Global Health | 1 | 2019 | 328 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 972 | 0.030 |
Why?
| | Stomach Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| | Clinical Coding | 1 | 2014 | 20 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 761 | 0.030 |
Why?
| | Mental Health | 1 | 2020 | 688 | 0.030 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2013 | 14 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 31136 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1843 | 0.030 |
Why?
| | Failure to Thrive | 1 | 2013 | 29 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 148 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2013 | 143 | 0.020 |
Why?
| | Celiac Disease | 1 | 2014 | 286 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1088 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7135 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2013 | 232 | 0.020 |
Why?
| | Eosinophilic Esophagitis | 1 | 2014 | 318 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1122 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1499 | 0.020 |
Why?
| | Pennsylvania | 1 | 2009 | 108 | 0.020 |
Why?
| | Nurses | 1 | 2011 | 166 | 0.020 |
Why?
| | Nurse-Patient Relations | 1 | 2007 | 63 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 997 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2009 | 546 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2009 | 848 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10219 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 383 | 0.010 |
Why?
|
|
Feinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|